Capital Impact Advisors, LLC United Therapeutics Corp Transaction History

Capital Impact Advisors, LLC

$3.16 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	BUY	$228.26 - $319.04 $683,866 - $955,843	2,996 New	2,996 $954,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $719,601 - $817,095	3,507 New	3,507 $774,000
Q3 2022 Nov 21, 2022	SELL	$203.3 - $244.17 $49,605 - $59,577	-244 Reduced 19.65%	998 $209,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $184,424 - $254,402	-1,055 Reduced 45.93%	1,242 $293,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $860,044 - $1.11 Million	-5,176 Reduced 69.26%	2,297 $412,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $1.38 Million - $1.61 Million	-7,473 Reduced 50.0%	7,473 $1.62 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $484,183 - $578,456	-2,692 Reduced 15.26%	14,946 $2.76 Million
Q1 2021 May 18, 2021	SELL	$153.94 - $174.85 $214,592 - $243,740	-1,394 Reduced 7.32%	17,638 $2.95 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $308,258 - $459,316	-3,026 Reduced 13.72%	19,032 $2.89 Million
Q2 2020 Aug 17, 2020	SELL	$92.74 - $125.82 $3.05 Million - $4.14 Million	-32,938 Reduced 59.89%	22,058 $2.67 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $252,936 - $367,505	3,186 Added 6.15%	54,996 $5.22 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $1.7 Million - $1.95 Million	22,714 Added 78.07%	51,810 $4.19 Million
Q2 2019 Jul 19, 2019	BUY	$76.06 - $120.81 $562,387 - $893,269	7,394 Added 34.07%	29,096 $2.24 Million
Q4 2018 Mar 08, 2019	SELL	$101.4 - $128.73 $184,852 - $234,674	-1,823 Reduced 7.75%	21,702 $2.28 Million
Q2 2018 Jul 25, 2018	BUY	$101.14 - $118.31 $436,823 - $510,980	4,319 Added 22.49%	23,525 $2.62 Million
Q1 2018 Apr 11, 2018	BUY	$107.21 - $151.94 $332,994 - $471,925	3,106 Added 19.29%	19,206 $2.16 Million
Q3 2017 Jan 16, 2018	BUY	$114.6 - $136.81 $1.85 Million - $2.2 Million	16,100	16,100 $1.89 Million

Others Institutions Holding UTHR

# of Institutions

668

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$1.99 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.61 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.16 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.04 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$815 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Account